Keywords: aventis, warner-lambert, loggerheads, over, antihistamine, study, pharma
Aventis and Warner-Lambert at loggerheads over antihistamine study
Article | 08 March 2000
Aventis Pharma's Allegra (fexofenadine) has less impact on drivingperformance than either Warner-Lambert's Benadryl (diphenhydramine) or alcohol, according to a study ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
